Ptc Therapeutics, Inc.
PTCTCIK 0001070081 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
51,853 bought / 51,853 sold
net +0 sh · −$2.49M
- buys
- 6
- sells
- 16
- insiders active
- 2
Filing tape
Filed Wed, Jul 8, 2026
- −0 sh · $211.9K
Boulding Mark Elliott — EXEC. VP AND CLO
- Exercised2,266Common Stock@ $39.42→ 107,538 held
- Sold313Common Stock@ $83.10→ 107,225 held
- Sold833Common Stock@ $84.41→ 106,392 held
- Sold519Common Stock@ $85.84→ 105,873 held
- Sold601Common Stock@ $86.38→ 105,272 held
- Exercised2,813Common Stock@ $46.54→ 108,085 held
- Sold387Common Stock@ $83.10→ 107,698 held
- Sold1,036Common Stock@ $84.41→ 106,662 held
- Sold645Common Stock@ $85.84→ 106,017 held
- Sold745Common Stock@ $86.38→ 105,272 held
- Exercised2,226Stock Option (Right to Buy)→ 4,532 held
- Exercised2,813Stock Option (Right to Buy)→ 28,125 held
- −0 sh · $2.28M
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
- Exercised811Common Stock@ $38.10→ 61,110 held
- Sold426Common Stock@ $85.28→ 60,684 held
- Sold385Common Stock@ $86.34→ 60,299 held
- Exercised18,876Common Stock@ $38.10→ 79,175 held
- Sold8,786Common Stock@ $85.35→ 70,389 held
- Sold10,090Common Stock@ $86.32→ 60,299 held
- Exercised2,474Common Stock@ $39.42→ 62,773 held
- Sold2,474Common Stock@ $87.03→ 60,299 held
- Exercised24,613Common Stock@ $39.42→ 84,912 held
- Sold3,956Common Stock@ $87.17→ 80,956 held
- Sold11,369Common Stock@ $89.03→ 69,587 held
- Sold9,288Common Stock@ $89.44→ 60,299 held
- Exercised811Stock Option (Right to Buy)→ 18,876 held
- Exercised18,876Stock Option (Right to Buy)→ 0 held
- Exercised2,474Stock Option (Right to Buy)→ 33,676 held
- Exercised24,613Stock Option (Right to Buy)→ 9,063 held
Insiders on this tape
- Boulding Mark ElliottEXEC. VP AND CLO
- Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.